1. Oróstica L, Astorga I, Plaza-Parrochia F, Vera C, García V, Carvajal R, et al. Proinflammatory environment and role of TNF-α in endometrial function of obese women having polycystic ovarian syndrome. Int J Obes (Lond) 2016 ;40:1715-1722. [ DOI:10.1038/ijo.2016.154] 2. Mohammadi S, Kayedpoor P, Karimzadeh-Bardei L, Nabiuni M. The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State. J Reprod Infertil 2017;18:352-360. 3. Ghowsi M, Khazali H, Sisakhtnezhad S. Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol. Iran J Basic Med Sci 2018;21:165-174. 4. Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, et al. Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int J Mol Sci 2021;22:3789. [ DOI:10.3390/ijms22073789] 5. Rostamtabar M, Esmaeilzadeh S, Tourani M, Rahmani A, Baee M, Shirafkan F, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol 2021;236:824-838. [ DOI:10.1002/jcp.29912] 6. Costello M, Garad R, Hart R, Homer H, Johnson L, Jordan C, et al. A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome. Med Sci (Basel) 2019;7:95. [ DOI:10.3390/medsci7090095] 7. Boots CE, Jungheim ES. Inflammation and Human Ovarian Follicular Dynamics. Semin Reprod Med 2015;33:270-5. [ DOI:10.1055/s-0035-1554928] 8. Liu Y, Liu H, Li Z, Fan H, Yan X, Liu X, et al. The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment. Front Immunol 2021;12:685724. [ DOI:10.3389/fimmu.2021.685724] 9. Velez LM, Seldin M, Motta AB. Inflammation and reproductive function in women with polycystic ovary syndrome†. Biol Reprod. 2021;104:1205-1217. [ DOI:10.1093/biolre/ioab050] 10. Liu C, Ding L, Yang H, Chen ZJEJ. Neck circumference is independently associated with metabolic syndrome in women with polycystic ovary syndrome. Endocr J 2022;69:809-18. [ DOI:10.1507/endocrj.EJ21-0761] 11. Yang H, Liu C, Jin C, Yu R, Ding L, Mu L. Neck Circumference Is Associated With Hyperuricemia in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2021;12:712855. [ DOI:10.3389/fendo.2021.712855] 12. Möhlig M, Spranger J, Osterhoff M, Ristow M, Pfeiffer AF, Schill T, et al. The polycystic ovary syndrome per se is not associated with increased chronic inflammation. Eur J Endocrinol 2004;150:525-32. [ DOI:10.1530/eje.0.1500525] 13. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001;25:1327-31. [ DOI:10.1038/sj.ijo.0801723] 14. Rocha AL, Oliveira FR, Azevedo RC, Silva VA, Peres TM, Candido AL, et al. Recent advances in the understanding and management of polycystic ovary syndrome. F1000Res 2019;8:F1000 Faculty Rev-565. [ DOI:10.12688/f1000research.15318.1] 15. Dams J, Liu Z, Ren YA, Wun WS, Zhou W, Kenigsberg S, et al. Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women with Polycystic Ovarian Syndrome. J Clin Endocrinol Metab 2016 S;101:3459-68. [ DOI:10.1210/jc.2015-4275] 16. Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 2003;101:1177-82. [ DOI:10.1097/00006250-200306000-00009] 17. Zhang T, Tian F, Huo R, Tang A, Zeng Y, Duan YG. Detection of dendritic cells and related cytokines in follicular fluid of patients with polycystic ovary syndrome. Am J Reprod Immunol 2017;78. [ DOI:10.1111/aji.12717] 18. Ghowsi M, Khazali H, Sisakhtnezhad S. Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol. Iran J Basic Med Sci 2018;21:165-174. 19. Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2011;335:30-41. [ DOI:10.1016/j.mce.2010.08.002] 20. Nehir Aytan A, Bastu E, Demiral I, Bulut H, Dogan M, Buyru F. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. Gynecol Endocrinol 2016;32:709-713. [ DOI:10.3109/09513590.2016.1155208] 21. Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009;26:163-70. [ DOI:10.1155/2009/465203] 22. Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 2013;12:86. [ DOI:10.1186/1476-4598-12-86] 23. Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study. Genet Test Mol Biomarkers 2014;18:605-9. [ DOI:10.1089/gtmb.2014.0151] 24. Mohammadi S, Kayedpoor P, Karimzadeh-Bardei L, Nabiuni M. The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State. J Reprod Infertil 2017;18:352-360. 25. Niu Z, Ye Y, Xia L, Feng Y, Zhang A. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization. Cytokine 2017;91:180-186. [ DOI:10.1016/j.cyto.2016.12.020] |
